Prokarium to present at ELRIG’s UK Forum 2025

Prokarium’s CSO, Livija Deban, will be presenting at the ELRIG’s “Outside the norm: Engineering biology for drug discovery” UK Forum, Warwick, UK, 13 November 2025.

Related News

London, UK – 16 February 2026 – Prokarium, a clinical-stage biopharmaceutical company pioneering bacterial immunotherapy for the treatment...
London, UK – November 11, 2025 – Prokarium, a clinical-stage biopharmaceutical company pioneering the field of microbial immunotherapy, today announced  the...
London, UK – November 11, 2025 – Prokarium, a clinical-stage biopharmaceutical company pioneering the field of microbial immunotherapy, today announced  the...
LONDON, United Kingdom, November 1, 2024 – Prokarium, a biopharmaceutical company developing innovative cancer treatments, today announced the...
LONDON, United Kingdom, November 1, 2024 – Prokarium, a biopharmaceutical company developing innovative cancer treatments, today announced the...